Phase 4 N=61 Randomized Triple-blind Treatment

Preoperative Pain Control in Gastric Bypass Surgery Patients

Post-operative Pain

Bottom Line

View on ClinicalTrials.gov: NCT01801189 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2022

Primary outcome: Primary: Post-operative Pain Medication Requirements — 13.76; 17.32; 40.89; 46.63 MME — p=0.10

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: Pregabalin (Drug); Placebo (for Pregabalin) (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Legacy Health System
Primary completion: Dec 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Post-operative Pain Medication Requirements	13.76; 17.32; 40.89; 46.63; 33.62; 29.74	0.10
SECONDARY Length of Stay	2.19; 2.24	—

Summary

Randomized clinical trial to evaluate whether a single pre-operative dose of Pregabalin will alleviate post-operative pain and decrease post-operative analgesic requirements in morbidly obese patients undergoing laparoscopic gastric bypass surgery.

Eligibility Criteria

Inclusion Criteria

Patients undergoing laparoscopic Roux-en-Y gastric bypass surgery.

Exclusion Criteria

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01801189). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.